LIPO

Lipella Pharmaceuticals, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website lipella.com
Employees(FY) 5
ISIN US53630L1008

Performance

+0.13%

1W

-1.34%

1M

-24.9%

3M

-30.62%

6M

-26.37%

YTD

-60.89%

1Y

Profile

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.

Advanced Technical Analysis

Technical Analysis of LIPO 2024-05-10

Overview:

In analyzing the technical indicators for LIPO stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around...

See more ...

Recent News & Updates

2024-04-16 20:00
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise(Globenewswire)
2024-04-04 20:00
Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024(Globenewswire)
2024-04-02 20:00
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis(Globenewswire)
2024-03-07 02:23
PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease(Yahoo Finance)
2024-03-04 19:00
Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline(Yahoo Finance)
2024-02-19 19:00
Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference(Globenewswire)
2023-12-19 19:00
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished(Globenewswire)
2023-11-12 07:20
Lipella Pharmaceuticals gets ODD for LP-310 to treat GvHD(Pharmaceutical-business-review)
2023-11-09 19:00
FDA Grants Orphan Designation for Lipella's LP-310 Drug Candidate for Oral Graft-versus-Host Disease(Prnewswire)
2023-10-25 04:05
Lipella Pharmaceuticals Announces Closing of $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules(Yahoo Finance)
2023-10-23 20:00
Lipella Pharmaceuticals Announces $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules(Yahoo Finance)
2023-10-22 20:45
Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma (PDAC) Intensely Increasing(Prnewswire)
2023-10-22 20:30
Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference(Yahoo Finance)
2023-10-19 20:00
Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-310 for Oral Lichen Planus(Yahoo Finance)
2023-09-20 20:30
Lipella Pharmaceuticals' Phase 2a Clinical Study Results Published in the Journal of Urology and Nephrology(Yahoo Finance)
2023-06-12 20:30
Lipella Pharmaceuticals: Addressing Significant Unmet Need for Cancer Survivors, Delivering Long Term Value for Shareholders(Yahoo Finance)
2023-05-14 21:15
Lipella Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update(Yahoo Finance)
2023-05-13 20:12
Lipella Pharmaceuticals First Quarter 2023 Earnings: US$0.19 loss per share (vs US$0.19 loss in 1Q 2022)(Yahoo Finance)
2023-04-30 20:30
Lipella Pharmaceuticals Delivers Late-Breaking Presentation at the American Urological Association Annual Meeting(Yahoo Finance)
2023-04-16 20:30
Lipella Pharmaceuticals Enters Manufacturing Collaboration Agreement with Cook MyoSite(Yahoo Finance)
2023-04-04 20:30
Lipella Pharmaceuticals Doses First Patient in Human Study of Innovative Contrast Agent(Yahoo Finance)
2023-03-30 20:00
Lipella Provides Business Update and Reports 2022 Financial Results(Yahoo Finance)
2023-03-15 20:30
Lipella Pharmaceuticals Successfully Completes Phase 2a Clinical Trial; Announces Late-Breaking Presentation at the Annual Meeting of the American Urological Association(Yahoo Finance)
2023-02-28 19:00
Lipella Pharmaceuticals Announces Creation of Oral Health Scientific Advisory Board(Yahoo Finance)
2023-01-10 18:30
Lipella Pharmaceuticals Announces Successful Top Line Results of Phase 2A Clinical Trial of LP-10(Yahoo Finance)
2023-01-08 19:00
Lipella Pharmaceuticals to Present at January 2023 Biotech Showcase in San Francisco(Yahoo Finance)
2022-12-22 03:05
Lipella Announces Closing of Initial Public Offering for Gross Proceeds of $7 Million(Yahoo Finance)

Page 1 of 1

previousnext